These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25066265)

  • 1. The hypotensive effect of the ruthenium complex [Ru(terpy)(bdq)NO]³⁺ is higher in male than in female spontaneously hypertensive rats (SHR).
    Potje SR; Hildebrand MC; Munhoz FC; Troiano JA; Pereira AA; Nakamune AC; da Silva RS; Bendhack LM; Antoniali C
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Nov; 387(11):1045-51. PubMed ID: 25066265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying the hypotensive and vasodilator effects of Ru(terpy)(bdq)NO](3+), a nitric oxide donor, differ between normotensive and spontaneously hypertensive rats.
    Potje SR; Munhoz FC; Perassa LA; Graton ME; Pereira AA; Nakamune AC; da Silva RS; Bendhack LM; Sumida DH; Antoniali C
    Eur J Pharmacol; 2014 Oct; 741():222-9. PubMed ID: 25179868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting hypotensive effect in renal hypertensive rats induced by nitric oxide released from a ruthenium complex.
    Rodrigues GJ; Pereira AC; Vercesi JA; Lima RG; Silva RS; Bendhack LM
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):193-8. PubMed ID: 22635073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO(+)](3+) in spontaneously hypertensive rats.
    Munhoz FC; Potje SR; Pereira AC; Daruge MG; da Silva RS; Bendhack LM; Antoniali C
    Nitric Oxide; 2012 Feb; 26(2):111-7. PubMed ID: 22245451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
    Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial modulation of a nitric oxide donor complex-induced relaxation in normotensive and spontaneously hypertensive rats.
    Potje SR; Troiano JA; Grando MD; Graton ME; da Silva RS; Bendhack LM; Antoniali C
    Life Sci; 2018 May; 201():130-140. PubMed ID: 29604271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress.
    Yanes L; Romero D; Iliescu R; Cucchiarelli VE; Fortepiani LA; Santacruz F; Bell W; Zhang H; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R903-8. PubMed ID: 15604302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.
    Schnackenberg CG; Welch WJ; Wilcox CS
    Hypertension; 1998 Jul; 32(1):59-64. PubMed ID: 9674638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central infusion of L-arginine or superoxide dismutase does not alter arterial pressure in SHR.
    Kagiyama S; Tsuchihashi T; Abe I; Matsumura K; Fujishima M
    Hypertens Res; 2000 Jul; 23(4):339-43. PubMed ID: 10912770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of kinin-induced hypotension by nitric oxide synthesis in spontaneously hypertensive rats.
    Bjørnstad-Ostensen A; Holte HR; Berg T
    Hypertension; 1997 Jan; 29(1 Pt 1):53-7. PubMed ID: 9039080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new inorganic vasodilator, trans-[Ru(NO)(NH(3))(4)(POEt)(3)](PF(6))(3): hypotensive effect of endothelium-dependent and -independent vasodilators in different hypertensive animals models.
    de Barros BF; Toledo JC; Franco DW; Tfouni E; Krieger MH
    Nitric Oxide; 2002 Aug; 7(1):50-6. PubMed ID: 12175820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
    de Richelieu LT; Sorensen CM; Holstein-Rathlou NH; Salomonsson M
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1227-34. PubMed ID: 16033921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation.
    Amaral JH; Montenegro MF; Pinheiro LC; Ferreira GC; Barroso RP; Costa-Filho AJ; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():446-455. PubMed ID: 23892053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zn deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn-superoxide dismutase.
    Sato M; Yanagisawa H; Nojima Y; Tamura J; Wada O
    Clin Exp Hypertens; 2002 Jul; 24(5):355-70. PubMed ID: 12109776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory blood pressure in female SHR to increased oxidative stress is not mediated by NO or by upregulation of renal antioxidant enzymes.
    Lopez-Ruiz AF; Iliescu R; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R266-71. PubMed ID: 20018822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with an extract of Terminalia superba Engler & Diels decreases blood pressure and improves endothelial function in spontaneously hypertensive rats.
    Tom EN; Girard-Thernier C; Martin H; Dimo T; Alvergnas M; Nappey M; Berthelot A; Demougeot C
    J Ethnopharmacol; 2014; 151(1):372-9. PubMed ID: 24212074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal L-arginine and antioxidant supplements reduce adult blood pressure but not ameliorate the altered vascular function in spontaneously hypertensive rats.
    de Queiroz DB; Ramos-Alves FE; Fernandes RL; Zuzu CP; Duarte GP; Xavier FE
    J Physiol Biochem; 2010 Dec; 66(4):301-9. PubMed ID: 20865358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Rut-bpy (Cis-[Ru(bpy)2(SO3)(NO)]PF 6), a novel nitric oxide donor, in L-NAME-induced hypertension in rats.
    Campelo MW; Campelo AP; Lopes LG; Santos AA; Guimarães SB; Vasconcelos PR
    Acta Cir Bras; 2011; 26 Suppl 1():57-9. PubMed ID: 21971659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide donor [Ru(terpy)(bdq)NO]
    Potje SR; Chen Z; Oliveira SDS; Bendhack LM; da Silva RS; Bonini MG; Antoniali C; Minshall RD
    Free Radic Biol Med; 2017 Nov; 112():587-596. PubMed ID: 28899725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.